Novel nox homologues in the vasculature: Focusing on Nox4 and Nox5

Clinical Science

Volumn 120, Issue 4, 2011, Pages 131-141

  Montezano, Augusto C ^a   Burger, Dylan ^a   Ceravolo, Graziela S ^a,b   Yusuf, Hiba ^a   Montero, Maria ^a,c   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Endothelium; Hydrogen peroxide; NADPH oxidase (Nox); Reactive oxygen species; Superoxide; Vascular smooth muscle cell

Indexed keywords

HYDROGEN PEROXIDE; ISOENZYME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; UNCLASSIFIED DRUG;

BIOSYNTHESIS; BLOOD VESSEL WALL; CALCIUM CELL LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SUBUNIT; HUMAN; KIDNEY CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASCULAR TISSUE;

ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 78751656380     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100384     Document Type: Review

References (104)

1. Briones, A. M. and Touyz, R. M. (2010) Oxidative stress and hypertension: current concepts. Curr. Hypertens. Rep. 12, 135-142
2. Petry, A., Weitnauer, M. and Gorlach, A. (2010) Receptor activation of NADPH oxidases. Antioxid. Redox Signaling 13, 467-487
3. Schröder, K. (2010) Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature. Curr. Opin. Pharmacol. 10, 122-126
4. Leto, T. L., Morand, S., Hurt, D. and Ueyama, T. (2009) Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid. Redox Signaling 11, 2607-2619
5. Arora, S., Vaishya, R., Dabla, P. K. and Singh, B. (2010) NAD(P)H oxidases in coronary artery disease. Adv. Clin. Chem. 50, 65-86
6. Geiszt, M., Kopp, J. B., Varnai, P. and Leto, T. L. (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97, 8010-8014
7. Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hattori, M., Sakaki, Y. and Sumimoto, H. (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276, 1417-1423
8. Yang, S., Zhang, Y., Ries, W. and Key, L. (2004) Expression of Nox4 in osteoclasts. J. Cell. Biochem. 92, 238-248
9. Dhaunsi, G. S., Kaur, J., Alsaeid, K., Turner, R. B. and Bitar, M. S. (2005) Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts. Cell Biochem. Funct. 23, 65-68
10. 2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24, 1844-1854
11. Schroder, K., Wandzioch, K., Helmcke, I. and Brandes, R. P. (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 29, 239-245
12. Chamulitrat, W., Stremmel, W., Kawahara, T., Rokutan, K., Fuji, H., Wingler, K., Schmidt, H. H. and Schmidt, R. (2004) A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes. J. Invest. Dermatol. 122, 1000-1009
13. Vallet, P., Charnay, Y., Steger, K., Ogier-Denis, E., Kovari, E., Herrmann, F., Michel, J. P. and Szanto, I. (2005) Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132, 233-238 (Pubitemid 40417898)
14. Dai, X., Cao, X. and Kreulen, D. L. (2006) Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 290, H1019-H1026
15. Clempus, R. E., Sorescu, D., Dikalova, A. E., Pounkova, L., Jo, P., Sorescu, G. P., Schmidt, H. H., Lassegue, B. and Griendling, K. K. (2007) Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27, 42-48
16. Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D. and Griendling, K. K. (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24, 677-683
17. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M. and Schmidt, H. H. (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radical Biol. Med. 31, 1456-1464
18. Van Buul, J. D., Fernandez-Borja, M., Anthony, E. C. and Hordijk, P. L. (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signaling 7, 308-317
19. Xu, S., He, Y., Vokurkova, M. and Touyz, R. M. (2009) Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin. Hypertension 54, 427-433
20. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R. E., Szocs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D. et al. (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435
21. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y. H., Takada, J., Wakisaka, M., Ibayashi, S., Utsumi, H. and Iida, M. (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109, 227-233
22. phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894
23. Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C. and Knaus, U. G. (2006) Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signalling 18, 69-82
24. Meng, D., Li, D. D. and Fang, J. (2008) Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc. Res. 80, 299-308
25. Basuroy, S., Bhattacharya, S., Leffler, C. W. and Parfenova, H. (2009) Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-α in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 296, C422-C432
26. Bedard, K. and Krause, K. H. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313
27. Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., Sienkiewicz, A., Forro, L., Schlegel, W. and Krause, K. H. (2007) NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem. J. 406, 105-114
28. Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassegue, B. and Griendling, K. K. (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259
29. Klaile, E., Muller, M. M., Kannicht, C., Otto, W., Singer, B. B., Reutter, W., Obrink, B. and Lucka, L. (2007) The cell adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1 regulates nucleocytoplasmic trafficking of DNA polymerase δ-interacting protein 38. J. Biol. Chem. 282, 26629-26640
30. Diaz, B., Shani, G., Pass, I., Anderson, D., Quintavalle, M. and Courtneidge, S. A. (2009) Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci. Signaling 2, ra53
31. Gordillo, G., Fang, H., Park, H. A. and Roy, S. (2010) Nox-4 dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation. Antioxid. Redox Signaling 12, 933-943
32. Dikalov, S. I., Dikalova, A. E., Bikineyeva, A. T., Schmidt, H. H., Harrison, D. G. and Griendling, K. K. (2008) Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radical Biol. Med. 45, 1340-1351
33. Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J. C., Pouzet, C., Samadi, M., Elbim, C. et al. (2004) NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24, 10703-10717
34. Chen, K., Kirber, M. T., Xiao, H., Yang, Y. and Keaney, Jr, J. F. (2008) Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181, 1129-1139
35. Santos, C. X., Tanaka, L. Y., Wosniak, J. and Laurindo, F. R. (2009) Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signaling 11, 2409-2427
36. Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K., Takeya, R., Kuribayashi, F., Imajoh-Ohmi, S., Igarashi, K., Shibata, Y., Sueishi, K. and Sumimoto, H. (2005) The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10, 1139-1151 (Pubitemid 41830073)
37. Miller, Jr, F. J. (2009) NADPH oxidase 4: walking the walk with Poldip2. Circ. Res. 105, 209-210
38. Hwang, J., Ing, M. H., Salazar, A., Lassegue, B., Griendling, K., Navab, M., Sevanian, A. and Hsiai, T. K. (2003) Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ. Res. 93, 1225-1232
39. Wosniak, J., Santos, C. X., Kowaltowski, A. J. and Laurindo, F. R. (2009) Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid. Redox Signaling 11, 1265-1278
40. Kalinina, N., Agrotis, A., Tararak, E., Antropova, Y., Kanellakis, P., Ilyinskaya, O., Quinn, M. T., Smirnov, V. and Bobik, A. (2002) Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 22, 2037-2043
41. Szocs, K., Lassegue, B., Sorescu, D., Hilenski, L. L., Valppu, L., Couse, T. L., Wilcox, J. N., Quinn, M. T., Lambeth, J. D. and Griendling, K. K. (2002) Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22, 21-27
42. Ismail, S., Sturrock, A., Wu, P., Cahill, B., Norman, K., Huecksteadt, T., Sanders, K., Kennedy, T. and Hoidal, J. (2009) NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-β1 and insulin-like growth factor binding protein-3. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L489-L499
43. 2-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-α. Int. Immunopharmacol. 8, 1377-1385
44. Manea, A., Manea, S. A., Gafencu, A. V., Raicu, M. and Simionescu, M. (2008) AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler. Thromb. Vasc. Biol. 28, 878-885
45. Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T. P., Hill, K., Sanders, K., Karwande, S. V., Stringham, J. C., Bull, D. A., Gleich, M. et al. (2006) Transforming growth factor-β1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L661-L673
46. Manea, A., Tanase, L. I., Raicu, M. and Simionescu, M. (2009) Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 30, 105-112
47. Zhang, L., Sheppard, O. R., Shah, A. M. and Brewer, A. C. (2008) Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F. Free Radical Biol. Med. 45, 679-685
48. Yamagishi, S., Nakamura, K., Ueda, S., Kato, S. and Imaizumi, T. (2005) Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 320, 437-445
49. Xu, H., Goettsch, C., Xia, N., Horke, S., Morawietz, H., Forstermann, U. and Li, H. (2008) Differential roles of PKCα and PKCε in controlling the gene expression of Nox4 in human endothelial cells. Free Radical Biol. Med. 44, 1656-1667
50. Goettsch, C., Goettsch, W., Arsov, A., Hofbauer, L. C., Bornstein, S. R. and Morawietz, H. (2009) Long-term cyclic strain downregulates endothelial Nox4. Antioxid. Redox Signaling 11, 2385-2397
51. Richard, D., Wolf, C., Barbe, U., Kefi, K., Bausero, P. and Visioli, F. (2009) Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway. Biochem. Biophys. Res. Commun. 389, 516-522
52. Hwang, J., Kleinhenz, D. J., Rupnow, H. L., Campbell, A. G., Thule, P. M., Sutliff, R. L. and Hart, C. M. (2007) The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vasc. Pharmacol. 46, 456-462
53. Bhandarkar, S. S., Jaconi, M., Fried, L. E., Bonner, M. Y., Lefkove, B., Govindarajan, B., Perry, B. N., Parhar, R., Mackelfresh, J., Sohn, A. et al. (2009) Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. J. Clin. Invest. 119, 2359-2365
54. Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., Ichiki, T., Takahashi, S. and Takeshita, A. (2003) Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93, 767-775
55. Alvarez, E., Rodino-Janeiro, B. K., Ucieda-Somoza, R. and Gonzalez-Juanatey, J. R. (2010) Pravastatin counteracts angiotensin II-induced up-regulation and activation of NADPH oxidase at plasma membrane of human endothelial cells. J. Cardiovasc. Pharmacol. 55, 203-212
56. Lee, S., Gharavi, N. M., Honda, H., Chang, I., Kim, B., Jen, N., Li, R., Zimman, A. and Berliner, J. A. (2009) A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radical Biol. Med. 47, 145-151
57. Simon, F. and Fernandez, R. (2009) Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J. Hypertens. 27, 1202-1216
58. Datla, S. R., Peshavariya, H., Dusting, G. J., Mahadev, K., Goldstein, B. J. and Jiang, F. (2007) Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 27, 2319-2324
59. Lener, B., Koziel, R., Pircher, H., Hutter, E., Greussing, R., Herndler-Brandstetter, D., Hermann, M., Unterluggauer, H. and Jansen-Durr, P. (2009) The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells. Biochem. J. 423, 363-374
60. Schilder, Y. D., Heiss, E. H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D. and Dirsch, V. M. (2009) NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radical Biol. Med. 46, 1598-1606
61. Sturrock, A., Huecksteadt, T. P., Norman, K., Sanders, K., Murphy, T. M., Chitano, P., Wilson, K., Hoidal, J. R. and Kennedy, T. P. (2007) Nox4 mediates TGF-β1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L1543-L1555
62. Dikalova, A., Clempus, R., Lassegue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D. S., Weiss, D. et al. (2005) Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112, 2668-2676 (Pubitemid 41532604)
63. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276, 37594-37601
64. Cheng, G., Cao, Z., Xu, X., van Meir, E. G. and Lambeth, J. D. (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131-140
65. BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C. and Görlach, A. (2007) NOX5 variants are functionally active in endothelial cells. Free Radical Biol. Med. 42, 446-459
66. Jay, D. B., Papaharalambus, C. A., Seidel-Rogol, B., Dikalova, A. E., Lassègue, B. and Griendling, K. K. (2008) Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radical Biol. Med. 45, 329-335
67. Kawahara, T., Quinn, M. T. and Lambeth, J. D. (2007) Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol. 7, 109
68. Fulton, D. J. (2009) Nox5 and the regulation of cellular function. Antioxid. Redox Signaling 11, 2443-2452
69. 2+ activation of the NADPH oxidase 5 (NOX5). J. Biol. Chem. 279, 18583-18591
70. Kawahara, T. and Lambeth, J. D. (2008) Phosphatidylinositol (4,5)-bisphosphate modulates Nox5 localization via an N-terminal polybasic region. Mol. Biol. Cell 19, 4020-4031
71. Tirone, F., Radu, L., Craescu, C. T. and Cox, J. A. (2010) Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of NOX5. Biochemistry 49, 761-771
72. Jagnandan, D., Church, J. E., Banfi, B., Stuehr, D. J., Marrero, M. B. and Fulton, D. J. (2007) Novel mechanism of activation of NADPH oxidase 5: calcium sensitization via phosphorylation. J. Biol. Chem. 282, 6494-6507
73. Serrander, L., Jaquet, V., Bedard, K., Plastre, O., Hartley, O., Arnaudeau, S., Demaurex, N., Schlegel, W. and Krause, K. H. (2007) NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie 89, 1159-1167
74. Tirone, F. and Cox, J. A. (2007) NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Lett. 581, 1202-1208
75. El Jamali, A., Valente, A. J., Lechleiter, J. D., Gamez, M. J., Pearson, D. W., Nauseef, W. M. and Clark, R. A. (2008) Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl. Free Radical Biol. Med. 44, 868-881
76. Wei, C. C., Motl, N., Levek, K., Chen, L. Q., Yang, Y. P., Johnson, T., Hamilton, L. and Stuehr, D. J. (2010) Conformational states and kinetics of the calcium binding domain of the NADPH oxidase 5. Open Biochem. J. 4, 59-67
77. Guzik, T. J., Chen, W., Gongora, M. C., Guzik, B., Lob, H. E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B. et al. (2008) Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J. Am. Coll. Cardiol. 52, 1803-1809
78. Montezano, A. C., Burger, D., Paravicini, T. M., Chignalia, A. Z., Yusuf, H., Almasri, M., He, Y., Callera, G. E., He, G., Krause, K. H. et al. (2010) Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ. Res. 106, 1363-1373
79. Si, J., Fu, X., Behar, J., Wands, J., Beer, D. G., Souza, R. F., Spechler, S. J., Lambeth, D. and Cao, W. (2007) NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-κB in Barrett's esophageal adenocarcinoma cells. J. Biol Chem. 282, 16244-16255
80. 2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. Am. J. Physiol. 270, H857-H868
81. Zhang, Q., Malik, P., Pandey, D., Gupta, S., Jagnandan, D., Belin de Chantemele, E., Banfi, B., Marrero, M. B., Rudic, R. D., Stepp, D. W. and Fulton, D. J. (2008) Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler. Thromb. Vasc. Biol. 28, 1627-1633
82. Paravicini, T. M. and Touyz, R. M. (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31, S170-S180
83. Boulanger, C. M., Amabile, N. and Tedgui, A. (2006) Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48, 180-186
84. Brodsky, S. V., Zhang, F., Nasjletti, A. and Goligorsky, M. S. (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am. J. Physiol. Heart Circ. Physiol. 286, H1910-H1915
85. Angelot, F., Seilles, E., Biichle, S., Berda, Y., Gaugler, B., Plumas, J., Chaperot, L., Dignat-George, F., Tiberghien, P., Saas, P. and Garnache-Ottou, F. (2009) Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 94, 1502-1512
86. Mostefai, H. A., Agouni, A., Carusio, N., Mastronardi, M. L., Heymes, C., Henrion, D., Andriantsitohaina, R. and Martinez, M. C. (2008) Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J. Immunol. 180, 5028-5035
87. McCrann, D. J., Yang, D., Chen, H., Carroll, S. and Ravid, K. (2009) Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy. Cell Cycle 8, 902-908
88. Knight, J. A. (2000) The biochemistry of aging. Adv. Clin. Chem. 35, 1-62
89. Jones, M. R. and Ravid, K. (2004) Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expression. J. Biol. Chem. 279, 5306-5313
90. Yang, D., McCrann, D. J., Nguyen, H., St Hilaire, C., DePinho, R. A., Jones, M. R. and Ravid, K. (2007) Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 6, 257-260
91. Herrera, M. D., Mingorance, C., Rodriguez-Rodriguez, R. and Alvarez de Sotomayor, M. (2010) Endothelial dysfunction and aging: an update. Ageing Res. Rev. 9, 142-152
92. Reference deleted
93. Schilder, Y. D., Heiss, E. H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D. and Dirsch, V. M. (2009) NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radical Biol. Med. 46, 1598-1606
94. Bao, X. M., Wu, C. F. and Lu, G. P. (2009) Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. Atherosclerosis 210, 114-121
95. Bismuth, J., Chai, H., Lin, P. H., Yao, Q. and Chen, C. (2009) Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Med. Sci. Monit. 15, 270-274
96. Schröder, K., Wandzioch, K., Helmcke, I. and Brandes, R. P. (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 29, 239-245
97. Lassègue, B. and Griendling, K. K. (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661
98. Clempus, R. E., Sorescu, D., Dikalova, A. E., Pounkova, L., Jo, P., Sorescu, G. P., Schmidt, H. H., Lassègue, B. and Griendling, K. K. (2007) Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27, 42-48
99. Anilkumar, N., Weber, R., Zhang, M., Brewer, A. and Shah, A. M. (2008) Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler. Thromb. Vasc. Biol. 28, 1347-1354
100. San Martín, A., Du, P., Dikalova, A., Lassègue, B., Aleman, M., Góngora, M. C., Brown, K., Joseph, G., Harrison, D. G., Taylor, W. R. et al. (2007) Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 292, H2073-H2082
101. Wendt, M. C., Daiber, A., Kleschyov, A. L., Mülsch, A., Sydow, K., Schulz, E., Chen, K., Keaney, Jr, J. F., Lassègue, B., Walter, U. et al. (2005) Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radical Biol. Med. 39, 381-391
102. Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L. and Miller, Y. I. (2009) Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104, 210-218
103. Hoch, N. E., Guzik, T. J., Chen, W., Deans, T., Maalouf, S. A., Gratze, P., Weyand, C. and Harrison, D. G. (2009) Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R208-R216
104. Von Löhneysen, K., Noack, D., Wood, M. R., Friedman, J. S. and Knaus, U. G. (2010) Structural insights into Nox4 and Nox2 motifs involved in function and cellular localization. Mol. Cell. Biol. 30, 961-975